Template-free self-assembling fullerene and lipopeptide conjugates of alamethicin form voltage-dependent ion channels of remarkable stability and activity

Journal of Peptide Science

Volumn 9, Issue 11-12, 2003, Pages 784-798

  Jung, Günther ^a   Redemann, Thomas ^a   Kroll, Karsten ^b   Meder, Sabine ^b   Hirsch, Andreas ^b   Boheim, Günther ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Alamethicin; Fullerene; Ion channels; Lipid bilayer membranes; Lipopeptides; Peptaibols

Indexed keywords

ALAMETHICIN; CYSTEINE DERIVATIVE; FULLERENE; ION CHANNEL; LIPOPEPTIDE; POLYSTYRENE DERIVATIVE; RESIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BACTERIAL CELL WALL; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ION CONDUCTANCE; LIPID BILAYER; MASS SPECTROMETRY; MEMBRANE CONDUCTANCE; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

ALAMETHICIN; CROSS-LINKING REAGENTS; DRUG STABILITY; ELECTROPHYSIOLOGY; FULLERENES; ION CHANNELS; LIPID BILAYERS; LIPOPROTEINS; MOLECULAR MIMICRY;

BACTERIA (MICROORGANISMS);

EID: 0345169918     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/psc.525     Document Type: Article

References (59)

1. Boheim G. Statistical analysis of alamethicin channels in black lipid membranes. J. Membr. Biol. 1974; 19: 277-303.
2. Akerfeldt KS, Lear JD, Wassermann ZR, Chung LA, DeGrado WF. Synthetic peptides as models for ion channel proteins. Acc. Chem. Res. 1993; 26: 191-197.
3. Gokel GW, Murillo O. Synthetic organic chemical models for transmembrane channels. Acc. Chem. Res. 1996; 29: 425-432.
4. Menestrina G, Voges KP, Jung G, Boheim G. Voltage-dependent channel formation by rods of helical polypeptides. J. Membr. Biol. 1986; 93: 111-132.
5. Vogel H, Nilsson L, Rigler R, Voges KP, Jung G. Structural fluctuations of a helical polypeptide traversing a lipid bilayer. Proc. Natl Acad. Sci. USA 1988; 85: 5067-5071.
6. Vogel H, Nilsson L, Rigler R, Meder S, Boheim G, Beck W, Kurth HH, Jung G. Structural fluctuations between two conformational states of a transmembrane helical peptide are related to its channel-forming properties in planar lipid membranes. Eur. J. Biochem. 1993; 212: 305-313.
7. Rink T, Bartel H, Jung G, Bannwarth W, Boheim G. Effects of polycations on ion channels formed by neutral and negatively charged alamethicins. Eur. Biophys. J. 1994; 23: 155-165.
8. Jung G. Natural peptide libraries of microbial and mammalian origin. In Combinatorial Peptide and Nonpeptide Libraries, Jung G (ed.). Verlag Chemie: Weinheim, 1996; 1-18.
9. Rizzo V, Schwarz G, Voges KP, Jung G. Molecular shape and dipole moment of alamethicin-like synthetic peptides. Eur. Biophys. J. 1985; 12: 67-73.
10. Schwarz G, Savko P, Jung G. Solvent-dependent structural features of the membrane active peptide trichotoxin A40 as reflected in its dielectric dispersion. Biochim. Biophys. Acta 1983; 728: 419-428.
11. Boheim G, Hanke W, Jung G. Alamethicin pore formation: voltage-dependent flip-flop of α-helix dipoles. Biophys. Struct. Mech. 1983; 9: 181-191.
12. Jung G, Bosch R, Katz E, Schmitt H, Voges KP, Winter W. The stabilizing effects of 2-methylalanine residues on β-turns and α-helices. Biopolymers 1983; 22: 241-246.
13. 1-7. Biopolymers 1979; 18: 425-450.
14. 10 helicity. Angew. Chem. 1984; 96: 440-443; Angew. Chem. Int. Ed. Engl. 1984; 23: 450-453.
15. Schmitt H, Jung G. Total synthesis of the α-helical eicosapeptide antibiotic alamethicin. Liebigs Ann. Chem. 1985; 1985: 321-344.
16. Redemann T, Jung G. In situ fluoride activation allows the preparation of peptides not accessible by routine synthesis protocols. In Peptides 1996, Proc. 24th Eur. Pept. Symp., 1998, Ramage R, Epton R (eds). Mayflower Scientific: Kingswinford, U.K. 1998; 749-750.
17. Boheim G, Helbig I, Meder S, Franz B, Jung G. Channel modelling experiments in planar bilayers using amphiphilic helical polypeptides. In Molecular Biology of Neuroreceptors and Ion Channels, Maelike A (ed.). Springer: Berlin. 1989; 401-412.
18. Voges KP, Jung G, Sawyer WH. Depth-dependent fluorescence quenching of a tryptophan residue located at defined positions on a rigid 21-peptide helix in liposomes. Biochim. Biophys. Acta 1987; 896: 64-76.
19. Wille B, Franz B, Jung G. Location and dynamics of alamethicin in unilamellar vesicles and thylakoids as model system. A spin label study. Biochim. Biophys. Acta 1989; 986: 47-60.
20. Metzger J, Wiesmüller KH, Schaude R, Bessler WG, Jung G. Synthesis of novel immunologically active tripalmitoyl-S-glycerylcysteinyl lipopeptides as useful intermediates for immunogen preparations. Int. J. Pept. Protein Res. 1991; 37: 46-57.
21. Skiebe A, Hirsch A. A facile method for the synthesis of amino acid and amido derivatives of C60. J. Chem. Soc. Chem. Commun. 1994; 3: 335-336.
22. Carpino LA, Beyermann M, Wenschuh H, Bienert M. Peptide synthesis via amino acid halides. Acc. Chem. Res. 1996; 29: 268-274.
23. Carpino LA, El-Faham A. Tetramethylfluoroformamidinium hexafluorophosphate: A rapid-acting peptide coupling reagent for solution and solid phase peptide synthesis. J. Am. Chem. Soc. 1995; 117: 5401-5402.
24. Wenschuh H, Beyermann M, Haber H, Seydel JK, Krause E, Bienert M. Stepwise automated solid phase synthesis of naturally occurring peptaibols using Fmoc amino acid fluorides. J. Org. Chem. 1995; 60: 405-410.
25. Thern B, Rudolph J, Jung G. Triphosgene as highly efficient reagent for the solid phase coupling of N-alkylated amino acids- total synthesis of cyclosporin O. Tetrahedron Lett. 2002; 43: 5013-5016.
26. Brückner H, Nicholson GJ, Jung G, Kruse K, König WA. Gas chromatographic determination of the configuration of isovaline in antiamoebin, samarosporin (Emericin IV), stilbellin, suzukacillins and trichotoxins. Chromatographia 1980; 13: 209-214.
27. Katz E, Aydin M, Lucht N, König WA, Ooka T, Jung G. Sequence and conformation of suzukacillin A. Liebigs Ann. Chem. 1985; 1985: 1041-1062.
28. Bayer E, Gfrörer P, Rentel C. Coordination - ionspray-MS (CIS-MS), a universal detection and characterization method for direct coupling with separation techniques. Angew. Chem. Int. Ed. Engl. 1999; 38: 992-995.
29. Wiesmüller KH, Bessler WG, Jung G. Solid phase peptide synthesis of lipopeptide vaccines eliciting epitope-specific B-, T-helper and T-killer cell response. Int. J. Pept. Protein Res. 1992; 40: 255-260.
30. Metzger J, Wiesmüller KH, Jung G. Synthesis of Nα-Fmoc protected derivatives of S-(2,3-dihydroxypropyl)-cysteine and their application in peptide synthesis. Int. J. Pept. Protein Res. 1991; 38: 545-554.
31. Metzger JW, Beck W, Jung G. Ion spray mass spectrometry of lipopeptide vaccines. Angew. Chem. 1992; 104: 235-237; Angew. Chem. Int. Ed. Engl. 1992; 31: 226-228.
32. Wiesmüller KH, Hess G, Bessler WG, Jung G. Diastereomers of tripalmitoyl-S-glyceryl-L-cysteinyl carrier adjuvant systems induce different mitogenic and protective immune response. In Chirality and Biological Activity, Homstedt B, Frank H, Testa B (eds). Alan R. Liss: New York, 1990; 267-272.
33. Wiesmüller KH, Jung G, Hess G. Novel low-molecular-weight synthetic vaccine against foot-and-mouth disease containing a potent B-cell and macrophage activator. Vaccine 1989; 7: 29-33.
34. Grove A, Tomich JM, Montal M. A molecular blueprint for the pore-forming structure of voltage-gated calcium channels. Proc. Natl Acad. Sci. USA 1991; 88: 6418-6422.
35. Matsubara A, Asami K, Akagi A, Nishino N. Ion-channels of cyclic template-assembled alamethicins that emulate the pore structure predicted by the barrel-stave model. J. Chem. Soc. Chem. Commun. 1996; 17: 2069-2071.
36. 4: Involvement of G-proteins and synergism with chemotactic peptides. Biochemistry 1990; 267: 795-802.
37. Aliprantis AO, Yang RB, Mark MR, Suggett S, Devaux B, Radolf JD, Klimpel GR, Godowski P, Zychlinsky A. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 1999; 285: 736-739.
38. Deres K, Schild HJ, Wiesmüller KH, Jung G, Rammensee HG. In vivo priming of virus specific cytotoxic T lymphocyte with synthetic lipopeptide vaccine. Nature 1989; 342: 561-564.
39. Wiesmüller KH, Jung G, Hess G. Novel low-molecular-weight synthetic vaccine against foot-and-mouth disease containing a potent B-cell and macrophage activator. Vaccine 1989; 7: 29-33.
40. Schild H, Norda M, Deres K, Falk K, Rötzschke O, Wiesmüller KH, Jung G, Rammensee HG. Fine specificity of cytotoxic T lymphocytes primed in vivo either with virus or synthetic lipopeptide vaccine or primed in vivo with peptide. J. Exp. Med. 1991; 174: 1665-1668.
41. Wiesmüller KH, Bessler WG, Jung G. Solid phase peptide synthesis of lipopeptide vaccines eliciting epitope-specific B-, T-helper and T-killer cell response. Int. J. Pept. Protein Res. 1992; 40: 255-260.
42. Praß W, Ringsdorf H, Bessler WG, Wiesmüller KH, Jung G. Lipopeptides of the N-terminus of Escherichia coli lipoprotein: synthesis, mitogenicity and properties in monolayer experiments. Biochim. Biophys. Acta 1987; 900: 116-128.
43. Uhl B, Speth V, Wolf B, Jung G, Bessler WG, Hauschildt S. Rapid alterations in the plasma membrane structure of macrophages stimulated with bacterial lipopeptides. Eur. J. Cell Biol. 1992; 58: 90-98.
44. Metzger JW, Sawyer WH, Wille B, Biesert L, Bessler WG, Jung G. Interaction of immunologically active lipopeptides with membranes. Biochim. Biophys. Acta 1993; 1149: 29-39.
45. 1 with lipopeptide analogues of bacterial lipoprotein: electron energy loss spectroscopy (EELS) as a novel method to detect the distribution of the activator within the cells. Immunbiology 1989; 180: 93-100.
46. Boncheva M, Duschl C, Beck W, Jung G, Vogel H. Formation and characterization of lipopeptide layers at interfaces for the molecular recognition of antibodies. Langmuir 1996; 12: 5636-5642.
47. Beck W, Metzger J, Wiesmüller KH, Jung G. Immunosensors on the basis of lipopeptides (Part of 'Biosensors Based on Receptors', by Jähnig F, Jung G, Gauglitz G, Göpel W). In Biosensors: Fundamentals, Technologies and Applications, Scheller F, Schmid RD (eds), GBF Monographs, Vol. 17, VCH Verlagsgesellschaft: Weinheim, 1992; 163-186.
48. DeGrado WF, Lear, JD. Conformationally constrained α-helical peptide models for protein ion channels. Biopolymers 1990; 29: 205-213.
49. Grove A, Tomich JM, Montal M. A molecular blueprint for the pore-forming structure of voltage-gated calcium channels. Proc. Natl Acad. Sci. USA 1991; 88: 6418-6422.
50. Matsubara A, Asami K, Akagi A, Nishino N. Ion-channels of cyclic template-assembled alamethicins that emulate the pore structure predicted by the barrel-stave model. J. Chem. Soc. Chem. Commun. 1996; 17: 2069-2071.
51. Woolley GA, Epand RM, Kerr ID, Sansom MSP, Wallace BA. Alamethicin pyromellitate: an ion-activated channel forming peptide. Biochemistry 1994; 33: 6850-6858.
52. You S, Peng S, Lien L, Breed J, Sansom MSP, Woolley A. Engineering stabilized ion channels: covalent dimers of alamethicin. Biochemistry 1996; 35: 6225-6232.
53. Schmitt JD, Sansom MSP, Kerr ID, Lunt GG, Eisenthal R. Ferrocenoyl derivatives of alamethicin: redox-sensitive ion channels. Biochemistry 1997; 36: 1115-1122.
54. Braun M, Camps X, Vostrowsky O, Hirsch A, Endreß E, Bayerl TM, Birkert O, Gauglitz G. Synthesis of a biotinylated lipofullerene as a new type of transmembrane anchor. Eur. J. Org. Chem. 2000: 1173-1181.
55. Hanke W, Methfessel C, Wilmsen HU, Katz E, Jung G, Boheim G. Melittin and a chemically modified trichotoxin form alamethicin-type multi-state pores. Biochim. Biophys. Acta 1983; 727: 108-114.
56. Baumann G, Mueller P. A molecular model of membrane excitability. J. Supramolec. Struct. 1974; 2: 538-557.
57. Chugh JK, Brückner H, Wallace BA. Model for a helical bundle channel based on the high-resolution crystal structure of trichotoxin-A50E. Biochemistry 2002; 41: 12 394-12 941.
58. Duclohier H, Molle G, Spach G. The influence of the trichozianin C-terminal residues on the ion channel conductance in lipid bilayers. Biochim. Biophys. Acta 1989; 987: 133-136.
59. Klumpp S, Jung G, Schultz JE. Activation of the calcium/calmodulin-dependent guanylate cyclase from Paramecium by polypeptide antibiotics and melittin. Biochim. Biophys. Acta 1984; 800: 145-151.